Skip to main content
Clinical Trials/IRCT20201127049502N1
IRCT20201127049502N1
Recruiting
Phase 3

Evaluating the effect of a combined mouthwash of triamcinolone acetonide 0.1% and Q10 coenzyme in the treatment of oral lichen planus

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
oral lichen planus.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
18
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with symptomatic oral lichen planus (erosive or atrophic form) who have a sense of burning or pain.
  • The diagnosis is clinical (Wickham striae or papules) and in cases in which a definitive diagnosis of the lesion is difficult, a histopathological evaluation will be used.
  • The patient should not have used topical corticosteroid treatments in the last two weeks or systemic corticosteroids in the last month.
  • The patient should not have used analgesics and anesthetics.

Exclusion Criteria

  • Patients with lichenoid lesions caused by medication or dental materials
  • Pregnant or lactating patients
  • Patients with other lesions such as leukoplakia and systemic lupus in conjunction with lichen planus
  • History of malignancy
  • Non\-cooperative patients and patients who do not use drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials